Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal
Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
Perrigo pays executives bonuses for fending off Mylan offers
Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus
Perrigo’s CEO confident shareholders will reject Mylan deal
Joseph Papa said shareholders are unlikely to accept a hostile $27.1 bn takeover bid from Mylan
Perrigo executives head for Israel in battle against Mylan
CEO Joe Papa and CFOJudy Brown hope to persuade Israeli holders of 10% of company not to accept takeover offer
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices